U.S. flag

An official website of the United States government

NM_004004.6(GJB2):c.426C>A (p.Phe142Leu) AND Rare genetic deafness

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 2, 2011
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000037852.5

Allele description [Variation Report for NM_004004.6(GJB2):c.426C>A (p.Phe142Leu)]

NM_004004.6(GJB2):c.426C>A (p.Phe142Leu)

Gene:
GJB2:gap junction protein beta 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q12.11
Genomic location:
Preferred name:
NM_004004.6(GJB2):c.426C>A (p.Phe142Leu)
HGVS:
  • NC_000013.11:g.20189156G>T
  • NG_008358.1:g.8820C>A
  • NM_004004.6:c.426C>AMANE SELECT
  • NP_003995.2:p.Phe142Leu
  • LRG_1350t1:c.426C>A
  • LRG_1350:g.8820C>A
  • LRG_1350p1:p.Phe142Leu
  • NC_000013.10:g.20763295G>T
  • NM_004004.5:c.426C>A
  • c.426C>A
Protein change:
F142L
Links:
dbSNP: rs397516877
NCBI 1000 Genomes Browser:
rs397516877
Molecular consequence:
  • NM_004004.6:c.426C>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Rare genetic deafness
Identifiers:
MedGen: C5680250; Orphanet: 96210

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000061514Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Pathogenic
(Sep 2, 2011)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided11not providednot providednot providedclinical testing

Citations

PubMed

A novel GJB2 (connexin 26) mutation, F142L, in a patient with unusual mucocutaneous findings and deafness.

Brown CW, Levy ML, Flaitz CM, Reid BS, Manolidis S, Hebert AA, Bender MM, Heilstedt HA, Plunkett KS, Fang P, Roa BB, Chung P, Tang HY, Richard G, Alford RL.

J Invest Dermatol. 2003 Nov;121(5):1221-3. No abstract available.

PubMed [citation]
PMID:
14708631

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000061514.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (2)

Description

The Phe142Leu variant GJB2 has been reported as a dominant variant in one indivi dual with sensorineural hearing loss and mucocutaneous findings (Brown 2003). Th is variant was shown to have occurred de novo and was absent in 214 control chro mosomes. This data meets our criteria for pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided1not provided1not provided

Last Updated: Dec 24, 2023